Showing results (201-210 of 369) with videos related to
Sort By:
Pageof 37
Clinical Transplantation|September 17, 2011
The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantationMing-Rui Huo, Lan-Ping Xu, D Li, et al.Bone Marrow Transplantation|December 7, 2018
Chemotherapy plus DLI for relapse after haploidentical HSCT: the biological characteristics of relapse influences clinical outcomes of acute leukemia patientsWei Sun, Xiao-Dong Mo, Xiao-Hui Zhang, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 29, 2018
Occurrence and Severity of Donor Lymphocyte Infusion-Associated Chronic Graft-versus-Host Disease Influence the Clinical Outcomes in Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell TransplantationWen-Jing Yu, Xiao-Dong Mo, Xiao-Hui Zhang, et al.Annals of Hematology|July 9, 2015
The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantationYu-Qian Sun, Gan-Lin He, Ying-Jun Chang, et al.Journal of Hematology & Oncology|June 12, 2012
Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemiaHuan Chen, Kai-yan Liu, Lan-ping Xu, et al.International Journal of Ophthalmology|September 20, 2021
Deletion of <i>prominin-1</i> in mice results in disrupted photoreceptor outer segment protein homeostasisYu-Shu Xiao, Jian Liang, Min Gao, et al.International Journal of Cancer|August 21, 2014
Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groupsXiao-Dong Mo, Lan-Ping Xu, Xiao-Hui Zhang, et al.Annals of Hematology|January 8, 2021
Allogeneic hematopoietic stem cell transplantation for intermediate-risk acute myeloid leukemia in the first remission: outcomes using haploidentical donors are similar to those using matched siblingsYan-Ru Ma, Lan-Ping Xu, Xiao-Hui Zhang, et al.Cell Transplantation|June 4, 2024
Basiliximab Treatment for Patients With Steroid-Refractory Acute Graft-Versus-Host Disease Following Matched Sibling Donor Hematopoietic Stem Cell TransplantationXin-Ya Jiang, Xiao-Hui Zhang, Lan-Ping Xu, et al.American Journal of Hematology|April 21, 2020
Prognostic factors and long-term follow-up of basiliximab for steroid-refractory acute graft-versus-host disease: Updated experience from a large-scale studySi-Ning Liu, Xiao-Hui Zhang, Lan-Ping Xu, et al.Pageof 37